Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00661375
What this trial is testing

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Not applicableStudy completedNCT06761742
What this trial is testing

Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests

Who this might be right for
Renal Tumors
RenJi Hospital 1,922
Early research (Phase 1)Study completedNCT01826877
What this trial is testing

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Jonsson Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)WithdrawnNCT04262375
What this trial is testing

Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

Who this might be right for
Non Small Cell Lung CancerRenal Cell Carcinoma
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT00903175
What this trial is testing

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 471
Testing effectiveness (Phase 2)Study completedNCT01462214
What this trial is testing

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Hans J. van der Vliet, MD, PhD 96
Large-scale testing (Phase 3)Study completedNCT02627963
What this trial is testing

Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00133887
What this trial is testing

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Who this might be right for
Skin CancerKidney Transplantation
Hospices Civils de Lyon 77
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Very early researchStudy completedNCT04804163
What this trial is testing

Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery

Who this might be right for
Renal Cell CarcinomaAdrenal TumorNonfunctioning Kidney
The Affiliated Hospital of Qingdao University 47
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Post-approval studies (Phase 4)Study completedNCT04513522
What this trial is testing

Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India

Who this might be right for
Kidney Neoplasms
Bristol-Myers Squibb 101
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Next Page